Tumor Board Reviews provides comprehensive coverage of all topics in oncology. Each of the 32 chapters focuses on a specific major disease. A brief overview of epidemiology and risk factors is followed by a sequence of specific presentations organized by tumors stage or disease classification. Each discussion features a case presentation that mimics the format of a tumor board presentation and thus illustrates key diagnostic and management decisions. There is also a discussion of the evidence that supports the clinical management decisions taken in the case, based on current expert panel guidelines. Algorithms and decision tree graphics are used extensively to provide visual support of the decision process. The combination of case presentations and evidence-based management discussions make this volume a unique tool for keeping current with clinical guidelines and provides the reader with a clear understanding of applications of new information for use in daily practice.

Now in its third edition, Oncology Board Review: Blueprint Study Guide and Q&A is designed to help you prepare for the American Board of Internal Medicine (ABIM) Medical Oncology Certification Exam. This comprehensive digital resource has been revised to include new treatment regimens, clinical guidelines, and other advancements impacting the field as well as updated board-style Q&A. Dedicated sections cover hematological malignancies and solid tumors with a templated chapter approach highlighting epidemiology, etiology and risk factors, diagnostic criteria, staging, signs and symptoms of the disease, prognostic factors, indications for treatment, and special considerations. Later sections address other topics found on the exam, including cancer genetics and tumor biology, supportive and palliative care, bone marrow transplantation, and biostatistics. With more than 240 practice questions and detailed rationales, Oncology Board Review gives you the tools to study your way and the confidence to pass the first time! Key Features: Aligns with the latest ABIM Medical Oncology Certification Exam blueprint Provides a comprehensive yet concise review of all hematologic malignancies and solid tumors Covers anticancer therapies, clinical research methodology, survivorship and palliative care, and more areas found on the exam Revised to include new treatment recommendations and FDA approvals Includes end-of-chapter assessment questions with detailed rationales - a total of more than 240 questions throughout

Print version of the book includes free access to the app (web, iOS, and Android), which offers interactive Q&A review plus the entire text of the print book! Please note the app is included with print purchase only. Oncology Board Review: Blueprint Study Guide and Q&A is a concise, outline-based study guide covering the topics that appear on the Medical Oncology Certification Exam. This second edition has been thoroughly revised to include new treatment regimens, clinical guidelines, and other updates impacting the field and reflected on the test. The book includes all topics listed in the American Board of Internal Medicine (ABIM) blueprint as essential material for the Medical Oncology Certification Exam. The coverage spans all hematologic malignancies and solid tumors, beginning with the epidemiology, and followed by the etiology and risk factors of the disease, staging, signs and symptoms, diagnostic criteria, indications for treatment, prognostic factors, treatment recommendations, and special considerations. Later chapters review other major subspecialty areas found on the exam including cancer genetics and tumor biology, supportive and palliative care, bone marrow transplantation, and biostatistics. Each chapter includes key points summarized in digestible bullets for easy recall and self-assessment. And, now containing over 230 board style questions with answers and detailed rationales, Oncology Board Review, Second Edition is the go-to, quick review for any trainee preparing for initial certification and for oncologists preparing for recertification. New to this Edition: Includes over 230 board style questions and answers with rationales New chapter on Bone Marrow Transplantation Thoroughly updated and revised chapters with all new treatment recommendations and FDA approvals for solid tumors and hematologic malignancies included.

In 2015, building on the advances of the Millennium Development Goals, the United Nations adopted Sustainable Development Goals that include an explicit commitment to achieve universal health coverage by 2030. However, enormous gaps remain between what is achievable in human health and where global health stands today, and progress has been both incomplete and unevenly distributed. In order to meet this goal, a deliberate and comprehensive effort is needed to improve the quality of health care services globally. Crossing the Global Quality Chasm: Improving Health Care Worldwide focuses on one particular shortfall in health care affecting global populations: defects in the quality of care. This study reviews the available evidence on the quality of care worldwide and makes recommendations to improve health care quality globally while expanding access to preventive and therapeutic services, with a focus in low-resource areas. Crossing the Global Quality Chasm emphasizes the organization and delivery of safe and effective care at the patient/provider interface. This study explores issues of access to services and commodities, effectiveness, safety, efficiency, and equity. Focusing on front line service delivery that can directly impact health outcomes for individuals and populations, this book will be an essential guide for key stakeholders, governments, donors, health systems, and others involved in health care.

Praise for the First Edition “As everyone in oncology fellowship training knows, there is a huge [information] gap in this field. Most oncology books are massive and loaded with information…by the time the book is [published]…it is outdated.” [Tumor Board Review] is fresh and just out of the oven…I haven’t seen any book in oncology like this so far…I think my investment in this book was wise and worth it.” — Humaid Al-Shamsi, MB(Hon), BMedSc, MRCP(UK), FRCP, FACP, Assistant Professor, The University of Texas, MD Anderson Cancer Center Culling the knowledge and expertise of respected oncology specialists, this is a concise yet comprehensive review of all areas of oncology practice for medical oncologists, radiation oncologists, and pathologists — both students and practitioners. The second edition of Tumor Board Review has been thoroughly revised to encompass recent scientific advances in assessment and treatment, new clinical guidelines, and new FDA-approved drugs and indications. It also contains approximately 250 multiple-choice questions and answers to assist readers in testing their knowledge, especially those preparing for the MOC exam. The book features case presentations and evidence-based management discussions that clearly demonstrate how to apply new information in daily practice. In a consistent format, each chapter addresses epidemiology, risk factors, natural history, and pathology of each major organ-specific tumor type; an abbreviated display of relevant staging; and several “tumor board style” illustrative patient case studies. This is followed by an evidence-based case discussion, which reinforces current guidelines and explains the rationale for the diagnostic and therapeutic steps taken. Algorithms and decision-tree graphics further illuminate the decision process. NEW TO THE SECOND EDITION OF TUMOR BOARD REVIEW: Presents the most recent guidelines and management standards in user-friendly format Focuses on current indications, use of new drugs, and new treatment of side effects Includes new FDA-approved drugs and guidelines Offers approximately 250 multiple-choice questions and answers

Breast Imaging presents a comprehensive review of the subject matter commonly encountered by practicing radiologists and radiology residents in training. This volume includes succinct overviews of breast cancer epidemiology, screening, staging, and treatment; overviews of all imaging modalities including mammography, tomosynthesis, ultrasound, and MRI; step-by-step approaches for image-guided breast interventions; and high-yield chapters organized by specific imaging finding seen on mammography, tomosynthesis, ultrasound, and MRI. Part of the Rotations in Radiology series, this book offers a guided approach to breast imaging interpretation and techniques, highlighting the nuances necessary to arrive at the best diagnosis and management. Each chapter contains a targeted discussion of an imaging finding which reviews the anatomy and physiology, distinguishing features, imaging techniques, differential diagnosis, clinical issues, key points, and further reading. Breast Imaging is a must-read for residents and practicing radiologists seeking a foundation for the essential knowledge base in breast imaging.

Cancer care today often provides state-of-the-science biomedical treatment, but fails to address the psychological and social (psychosocial) problems associated with the illness. This failure can compromise the effectiveness of health care and thereby adversely affect the health of cancer patients. Psychological and social problems created or exacerbated by cancer-including depression and other emotional problems; lack of information or skills needed to manage the illness; lack of transportation or other resources; and disruptions in work, school, and family life-cause additional suffering, weaken adherence to prescribed treatments, and threaten patients' return to health. Today, it is not possible to deliver high-quality cancer care without using existing approaches, tools, and resources to address patients' psychosocial health needs. All patients with cancer and their families should expect and receive cancer care that ensures the provision of appropriate psychosocial health services. Cancer Care for the Whole Patient recommends actions that oncology providers, health policy makers, educators, health insurers, health planners, researchers and research sponsors, and consumer advocates should undertake to ensure that this standard is met.